Protein-losing enteropathy is associated with Clostridium difficile diarrhea but not with asymptomatic colonization: A prospective, case-control study

Clinical Infectious Diseases

Volumn 22, Issue 6, 1996, Pages 932-937

  Dansinger, Michael L ^b   Johnson, Stuart ^b   Jansen, Peter C ^b   Opstad, Nancy L ^b   Bettin, Kristine M ^b   Gerding, Dale N ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; CHOLESTEROL; SERUM ALBUMIN; TRANSFERRIN;

ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; DIARRHEA; FEMALE; HUMAN; MALE; MALNUTRITION; NURSING HOME; NUTRITIONAL STATUS; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN LOSING GASTROENTEROPATHY; TRANSFERRIN BLOOD LEVEL;

EID: 0029784317     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/22.6.932     Document Type: Article

References (28)

1. Gerding DN, Olson MM, Peterson LR, et al. Clostridium difficile-associated diarrhea and colitis in adults. A prospective case-controlled epidemic-logic study. Arch Intern Med 1986;146:95-100.
2. Bartlett JG, Chang TW, Gurwith M, Gorbach SL, Onderdonk AB. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med 1978;298:531-4.
3. Rybolt AH, Bennett RG, Laughon BE, Thomas DR, Greenough WB III, Bartlett JG. Protein-losing enteropathy associated with Clostridium difficile infection. Lancet 1989;1:1353-5.
4. Bender BS, Bennett R, Laughon BE, et al. Is Clostridium difficile endemic in chronic-care facilities? Lancet 1986;2:11-3.
5. Burdon DW. Clostridium difficile: the epidemiology and prevention of hospital-acquired infection [editorial]. Infection 1982;10:203-4.
6. Savage AM, Alford RH. Nosocomial spread of Clostridium difficile. Infect Control 1983;4:31-3.
7. Johnson S, Clabots CR, Linn FV, Olson MM, Peterson LR, Gerding DN. Nosocomial Clostridium difficile colonisation and disease. Lancet 1990;336:97-100.
8. Herman BE, Vargo J, Phillips WS, Sweeny WB, Volpe RJ. Antibiotic-associated fulminant pseudomembranous colitis without toxic megacolon. Am J Gastroenterol 1992;87:1816-9.
9. Aronsson B, Blombäck M, Eriksson S, Egberg N. Low levels of coagulation inhibitors in patients with Clostridium difficile infection. Infection 1992;20:58-60.
10. Rudman D, Feller AG. Protein-calorie undernutrition in the nursing home. J Am Geriatr Soc 1989;37:173-83.
11. McFarland LV, Coyle MB, Kremer WH, Stamm WE. Rectal swab cultures for Clostridium difficile surveillance studies. J Clin Microbiol 1987;25:2241-2.
12. George WL, Sutter VL, Citron D, Finegold SM. Selective and differential medium for isolation of Clostridium difficile. J Clin Microbiol 1979;9:214-9.
13. Holdeman LV, Cato EP, Moore WEC, eds. Anaerobe laboratory manual. 4th ed. Blacksburg, Virginia: Virginia Polytechnic Institute and State University, 1977:94-105.
14. Shanholtzer CJ, Petersen LR, Olson MN, Gerding DN. Prospective study of gram-stained stool smears in diagnosis of Clostridium difficile colitis. J Clin Microbiol 1983;17:906-8.
15. 1-antitrypsin in fecal extracts by enzyme immunoassay. Clin Chim Acta 1990;189:173-80.
16. 1-antitrypsin concentration by radial immunodiffusion: two systems compared. Clin Chem 1988;34:372-6.
17. Buzby GP, Mullen JL. Analysis of nutritional assessment indices-prognostic equations and cluster analysis. In: Wright RA, Heymsfield S, eds. Nutritional assessment. Boston: Blackwell, 1984:144-7.
18. el-Hawy AM, Abou-Taleb SA, Massoud AM, Abdel-Khalek YH. α-1 antitrypsin and electrolytes in some cases of diarrhea. J Egypt Soc Parasitol 1989;19(1):131-7.
19. Samore MH, Bettin KM, DeGirolami PC, Clabots CR, Gerding DN, Karchmer AW. Wide diversity of Clostridium difficile types at a tertiary referral hospital. J Infect Dis 1994;170:615-21.
20. Teasley DG, Gerding DN, Olson MM, et al. Prospective randomised trial of metronidazole versus vancomycin for Clostridium difficile-associated diarrhoea and colitis. Lancet 1983;2:1043-6.
21. 1-antitrypsin and colonization with Clostridium difficile in asymptomatic infants. J Pediatr 1985;107:257-9.
22. Johnson S, Homman SR, Bettin KM, et al. Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole. A randomized, placebo-controlled trial. Ann Intern Med 1992;117:297-302.
23. Johnson S, Adelmann A, Clabots CR, Peterson LR, Gerding DN. Recurrences of Clostridium difficile diarrhea not caused by the original infecting organism. J Infect Dis 1989;159:340-3.
24. 1-antitrypsin: a sensitive method for the detection of protein-losing enteropathy. Gastroenterology 1981;81:777-80.
25. Crossley JR, Elliott RB. Simple method for diagnosing protein-losing enteropathies. Br Med J 1977;1:428-9.
26. 1-antitrypsin. Am J Clin Pathol 1985;83:326-30.
27. 1-antitrypsin clearance in patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1984;3:56-61.
28. Stufler MH, Ewe K, Gierlasinski B, Prün H, Zutt M. Erhöhtes Serum-alpha-1-Antitrypsin verursacht bei darmgesunden Patienten keinen Anstieg des fäkalen alpha-1-Antitrypsin. Z Gastroenterol 1991;29(1): 11-5.